Abstract
Background
Surgery is the treatment of choice for localized esophageal and gastric cardia cancer. Our aim was to evaluate factors influencing postoperative short-term morbidity, 30-day mortality, and long-term prognosis.
Methods
We identified 232 patients who had undergone surgical resection from a Swedish nationwide case control study of cancer of the esophagus and cardia between December 1, 1994 and December 31, 1997. Patients’ demographics, tumor characteristics, preoperative investigations, and treatments were reviewed. Patients were followed up through linkage to the Death Registry until December 2004. Survival curves were estimated by the Kaplan-Meier method. Cox proportional hazards regression models were used to derive hazard ratios (HRs) with 95% confidence intervals (CIs).
Results
The overall 5-year survival rate was 25%. Tumor stage was the most prominent prognostic factor for long-term survival. Low-volume hospital (HR = 1.3, 95% CI = 1.0–1.9), low-volume surgeon (HR = 1.4, 95% CI = 1.0-2.0), and postoperative need for respirator support (HR = 1.4, 95% CI = 1.0–1.9), were associated with a worse prognosis. Patients treated at low-volume hospitals or by low-volume surgeons needed respirator support more often or stayed longer at intensive care units after surgery.
Conclusion
Patients with esophageal cancer have a modestly poorer prognosis when operated on at low-volume centers or by surgeons with less experience with esophageal cancer surgery.
Similar content being viewed by others
References
Sundelof M, Ye W, Dickman PW et al (2002) Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 99(5):751–754
DeMeester SR (2006) Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 13(1):12–30
Burmeister BH, Smithers BM, Gebski V et al (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6(9):659–668
Conti S, West JP, Fitzpatrick HF (1977) Mortality and morbidity after esophagogastrectomy for cancer of the esophagus and cardia. Am Surg 43(2):92–96
Hofstetter W, Swisher SG, Correa AM et al (2002) Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-384; discussion 384–385
Rouvelas I, Zeng W, Lindblad M et al (2005) Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6(11):864–870
Stein HJ, Siewert JR (2004) Improved prognosis of resected esophageal cancer. World J Surg 28(6):520–525
Altorki NK, Girardi L, Skinner DB (1997) En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 114(6):948–955; discussion 955–956
Ando N, Ozawa S, Kitagawa Y et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232
Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137
Birkmeyer JD, Stukel TA, Siewers AE et al (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127
Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222(5):654–662
Holscher AH, Bollschweiler E, Bumm R et al (1995) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118(5):845–855
Portale G, Peters JH, Hagen JA et al (2005) Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. Arch Surg 140(6):570–574; discussion 574–575
Siewert JR, Stein HJ, Feith M et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234(3):360–367; discussion 368–369
Xiao ZF, Yang ZY, Miao YJ et al (2005) Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 62(1):82–90
Greene FLPD, Fleming ID (2002) AJCC cancer staging manual, 6 ed. Springer-Verlag, New York
Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90(3):139-146; discussion 146
Jamieson GG, Mathew G, Ludemann R et al (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 91(8):943–947
Finlayson EV, Goodney PP, Birkmeyer JD (2003) Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 138(7):721–725; discussion 726
Holscher AH, Metzger R, Brabender J et al (2004) High-volume centers–effect of case load on outcome in cancer surgery. Onkologie 27(4):412–416
Viklund P, Lindblad M, Lu M et al (2006) Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 243(2):204–211
Birkmeyer NJ, Goodney PP, Stukel TA et al (2005) Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103(3):435–441
Casson AG, van Lanschot JJ (2005) Improving outcomes after esophagectomy: the impact of operative volume. J Surg Oncol 92(3):262–266
Wenner J, Zilling T, Bladstrom A et al (2005) The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia. Anticancer Res 25(1B):419–424
Rouvelas I, Lindblad M, Zeng W et al (2007) Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg 142(2):113–117
Brucher BL, Stein HJ, Werner M et al (2001) Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer 92(8):2228–2233
Fujita H, Sueyoshi S, Tanaka T et al (2003) Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg 27(5):571–579
Lindblad M, Ye W, Lindgren A et al (2006) Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 243(4):479–485
Acknowledgments
This study was supported by a grant (R01 CA57947-03) from the National Cancer Institute, and by a grant from Cancerfonden.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sundelöf, M., Lagergren, J. & Ye, W. Surgical Factors Influencing Outcomes in Patients Resected for Cancer of the Esophagus or Gastric Cardia. World J Surg 32, 2357–2365 (2008). https://doi.org/10.1007/s00268-008-9698-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-008-9698-2